Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind Study of the Effect of RO4607381 in Combination With Pravastatin on HDL-cholesterol (HDL-C) Levels in Patients With Low or Average HDL-C Levels
Conditions
Interventions
Placebo
Pravastatin
+3 more
Locations
33
United States
Mobile, Alabama, United States
Scottsdale, Arizona, United States
Newark, Delaware, United States
Miami, Florida, United States
Chicago, Illinois, United States
Evansville, Indiana, United States
Start Date
July 1, 2005
Primary Completion Date
May 1, 2006
Completion Date
May 1, 2006
Last Updated
January 2, 2020
NCT07238556
NCT06314919
NCT07162441
NCT06935513
NCT06932705
NCT06568471
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions